Ethyl loflazepate
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401519This classification denotes a benzodiazepine with the molecular formula C18H14ClFN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VJB5FW9W9J, chemically known as 1h-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro but generally known as ethyl loflazepate, which bears US NIH Compound Identifier 3299. European Medicines Agency schedules Ethyl loflazepate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07290MIG. The term ETHYL LOFLAZEPATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules ethyl loflazepate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ethyl loflazepate under HS 29339190 and SITC 51577. As of Q4 2014, ETHYL LOFLAZEPATE remains the US FDA Preferred Term for this commodity. Ethyl loflazepate bears US NLM identifiers UMLS ID C0059772 and NCI Concept Code C65566. SMILES: CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.